HSV amplicons: neuro applications.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Current Gene Therapy

• Publication date

  2006-05-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/156652306777592045PMID 16787185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic potential of neurotrophins for treatment of hearing loss

  2007cited by this paper
• Testing the Possibility to Protect Bovine PrPC Transgenic Swiss Mice Against Bovine PrPSc Infection by DNA Vaccination Using Recombinant Plasmid Vectors Harboring and Expressing the Complete or Partial cDNA Sequences of Bovine PrPc

  2005cited by this paper
• Circumventing Tolerance to the Prion Protein (PrP): Vaccination with PrP-Displaying Retrovirus Particles Induces Humoral Immune Responses against the Native Form of Cellular PrP

  2005cited by this paper
• Paracrine Inhibition of Prion Propagation by Anti-PrP Single-Chain Fv Miniantibodies

  2005cited by this paper
• Mucosal vaccination delays or prevents prion infection via an oral route.

  2005cited by this paper
• DNA and Adenoviral Vectors Encoding Carcinoembryonic Antigen Fused to Immunoenhancing Sequences Augment Antigen-Specific Immune Response and Confer Tumor Protection

  2005cited by this paper
• DNA fusion gene vaccines against cancer: from the laboratory to the clinic

  2004cited by this paper
• Anti‐PrP antibodies block PrPSc replication in prion‐infected cell cultures by accelerating PrPC degradation

  2004cited by this paper
• Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection

  2004cited by this paper
• Reversal and consolidation of activity-induced synaptic modifications.

  2004cited by this paper
• Receptor trafficking and synaptic plasticity

  2004cited by this paper
• Sm14 of Schistosoma mansoni in Fusion with Tetanus Toxin Fragment C Induces Immunoprotection against Tetanus and Schistosomiasis in Mice

  2004cited by this paper
• Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.

  2003cited by this paper
• Scrapie and experimental BSE in sheep.

  2003cited by this paper
• Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice.

  2003cited by this paper
• Monoclonal antibodies inhibit prion replication and delay the development of prion disease

  2003cited by this paper
• Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization

  2003cited by this paper
• Polyclonal Anti-PrP Auto-antibodies Induced with Dimeric PrP Interfere Efficiently with PrPSc Propagation in Prion-infected Cells*

  2003cited by this paper
• Alzheimer vaccine: amyloid-beta on trial.

  2003cited by this paper
• Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementation of low-density lipoprotein receptor deficiency in human cells.

  2003cited by this paper
• Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

  2003cited by this paper
• Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent.

  2003cited by this paper
• Setback for an Alzheimer’s disease vaccine

  2003cited by this paper
• Vaccines for Alzheimer’s Disease

  2003cited by this paper
• Regional heterogeneity of cellular prion protein isoforms in the mouse brain.

  2003cited by this paper
• Infectious delivery of 120-kilobase genomic DNA by an epstein-barr virus amplicon vector.

  2002cited by this paper
• Inflammation and therapeutic vaccination in CNS diseases

  2002cited by this paper
• Rapid Tyrosine Phosphorylation of Neuronal Proteins Including Tau and Focal Adhesion Kinase in Response to Amyloid-β Peptide Exposure: Involvement of Src Family Protein Kinases

  2002cited by this paper
• Expression of Human Immunodeficiency Virus Type 1 gp120 from Herpes Simplex Virus Type 1-Derived Amplicons Results in Potent, Specific, and Durable Cellular and Humoral Immune Responses

  2002cited by this paper
• Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease

  2002cited by this paper
• Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses.

  2002cited by this paper
• Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway.

  2002cited by this paper
• Herpes Simplex Virus Type 1 Amplicon Vector-Mediated Gene Transfer to Muscle

  2002cited by this paper
• Immunization delays the onset of prion disease in mice.

  2002cited by this paper
• Neurotrophin-3 transduction attenuates cisplatin spiral ganglion neuron ototoxicity in the cochlea.

  2002cited by this paper
• Antibodies inhibit prion propagation and clear cell cultures of prion infectivity

  2001cited by this paper
• Neurotrophins as synaptic modulators

  2001cited by this paper
• Dendritic Cells Transduced with HSV-1 Amplicons Expressing Prostate-Specific Antigen Generate Antitumor Immunity in Mice

  2001cited by this paper
• An infectious transfer and expression system for genomic DNA loci in human and mouse cells

  2001cited by this paper
• Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody

  2001cited by this paper
• Immune hyporesponsiveness to amyloid β-peptide in amyloid precursor protein transgenic mice: Implications for the pathogenesis and treatment of Alzheimer's disease

  2001cited by this paper
• Prevention of Scrapie Pathogenesis by Transgenic Expression of Anti-Prion Protein Antibodies

  2001cited by this paper
• HSV amplicon-mediated neurotrophin-3 expression protects murine spiral ganglion neurons from cisplatin-induced damage.

  2001cited by this paper
• Modulation of proteinase‐K resistant prion protein by prion peptide immunization

  2001cited by this paper
• A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.

  2000cited by this paper
• A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.

  2000cited by this paper
• Enhanced Learning in Mice Parallels Vector-Mediated Nerve Growth Factor Expression in Hippocampus

  2000cited by this paper
• Tetanus Toxin Fragment C Expressed in LiveSalmonella Vaccines Enhances Antibody Responses to Its Fusion Partner Schistosoma haematobium GlutathioneS-Transferase

  2000cited by this paper
• Gene-experience interaction alters the cholinergic septohippocampal pathway of mice.

  2000cited by this paper
• Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease

  2000cited by this paper
• Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells.

  2000cited by this paper
• Evidence that nerve growth factor influences recent memory through structural changes in septohippocampal cholinergic neurons

  1999cited by this paper
• Inhibition of dendritic cell maturation by herpes simplex virus

  1999cited by this paper
• Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

  1999cited by this paper
• Long-term stability of large insert genomic DNA episomal shuttle vectors in human cells.

  1999cited by this paper
• Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis.

  1999cited by this paper
• Kinetics of prion protein accumulation in the CNS of mice with experimental scrapie.

  1999cited by this paper
• Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination.

  1999cited by this paper
• Impaired learning and motor behavior in heterozygous Pafah1b1 (Lis1) mutant mice.

  1999cited by this paper
• Gene Therapy in the Inner Ear: Mechanisms and Clinical Implications

  1999cited by this paper
• Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau

  1998cited by this paper
• Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss

  1998cited by this paper
• The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism.

  1998cited by this paper
• DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C.

  1997cited by this paper
• Lack of Neurotrophin 3 Causes Losses of Both Classes of Spiral Ganglion Neurons in the Cochlea in a Region-Specific Fashion

  1997cited by this paper
• Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss

  1997cited by this paper
• Protection of both auditory hair cells and auditory neurons from cisplatin induced damage.

  1997cited by this paper
• Prion (PrPSc)-specific epitope defined by a monoclonal antibody

  1997cited by this paper
• Effects of a single intraseptal injection of NGF on spatial learning in the water maze.

  1997cited by this paper
• Immunopathogenesis of herpetic ocular disease

  1997cited by this paper
• Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3

  1996cited by this paper
• NT‐3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells

  1996cited by this paper
• NGF, BDNF and NT-3 play unique roles in the in vitro development and patterning of innervation of the mammalian inner ear.

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein.

  1996cited by this paper
• Defective HSV-1 Vector Expressing BDNF in Auditory Ganglia Elicits Neurite Outgrowth: Model for Treatment of Neuron Loss Following Cochlear Degeneration

  1996cited by this paper
• Gene transfer to neurons using herpes simplex virus-based vectors.

  1996cited by this paper
• The role of the neurotrophins in maturation and maintenance of postnatal auditory innervation.

  1996cited by this paper
• The role of PrP in pathogenesis of experimental scrapie.

  1996cited by this paper
• Enhanced preservation of the auditory nerve following cochlear perfusion with nerve growth factors.

  1995cited by this paper
• Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia.

  1995cited by this paper
• Neurotrophins and Neuronal Plasticity

  1995cited by this paper
• p53‐Immunoreactive Protein and p53 mRNA Expression After Transient Middle Cerebral Artery Occlusion in Rats

  1994cited by this paper
• Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia.

  1994cited by this paper
• Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector.

  1994cited by this paper
• DNA damage consistent with apoptosis in transient focal ischaemic neocortex.

  1994cited by this paper
• Neurotrophin and neurotrophin receptor mRNA expression in developing inner ear.

  1994cited by this paper
• bcl-2 inhibits death of central neural cells induced by multiple agents.

  1993cited by this paper
• Expression patterns of neurotrophin and their receptor mRNAs in the rat inner ear.

  1993cited by this paper
• Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat.

  1993cited by this paper
• Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain.

  1993cited by this paper
• Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species.

  1993cited by this paper
• Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor.

  1993cited by this paper
• Evidence Supporting a Role for Programmed Cell Death in Focal Cerebral Ischemia in Rats

  1993cited by this paper
• The TINS/TiPS Lecture. The molecular biology of mammalian glutamate receptor channels.

  1993cited by this paper
• BCL-2 blocks glutamate toxicity in neural cell lines.

  1993cited by this paper
• Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene.

  1993cited by this paper
• Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA

  1991cited by this paper
• Environmental influence on behaviour and nerve growth factor in the brain.

  1990cited by this paper
• Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation.

  1989cited by this paper

• Viral‐Mediated Delivery of shRNA and miRNA

  2013cites this paper
• Development of gene therapy for neurological disorders.

  2010cites this paper
• Progress and prospects: Biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors

  2009cites this paper
• HSV-1-derived amplicon vectors: recent technological improvements and remaining difficulties--a review.

  2009influential citation
• Gene Therapy: Direct Viral Delivery

  2009cites this paper
• Engineering Viruses for CNS studies

  2009cites this paper
• Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.

  2008influential citation
• Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag.

  2007cites this paper
• Imaging CD8+ T cell dynamics in vivo using a transgenic luciferase reporter.

  2007cites this paper
• HSV-1 amplicon vectors

  2007cites this paper